Holding the Lead! Hansoh Pharma Maintains Third Place as "Best Industrial Enterprise for Pharmaceutical R&D Product Line in China"
On November 18, the 2023 (40th) China Pharmaceutical Industry Information Annual Conference was officially launched in Beijing, where the highly anticipated rankings for the Top 100 Chinese Pharmaceutical Industries in 2022, along with a series of special rankings, were ceremoniously released by the Ministry of Industry and Information Technology. Hansoh Pharma's chief subsidiary, Jiangsu Hansoh Pharma, has been ranked among the Top 100 Chinese Pharmaceutical Industries for several consecutive years. Boasting outstanding R&D capabilities and highly successful innovative achievements, it ranked third in the "Best Industrial Enterprise for Pharmaceutical R&D Product Line in China for 2023".